Short Interest Worth Mentioning Today: Does BLAKE INSOMNIA THERAPEUTICS INCORPORATED (OTCMKTS:BKIT) Have Gas After Even More Sellers Involved?

November 25, 2016 - By Richard Conner   ·   0 Comments

Short Interest Worth Mentioning Today: Does BLAKE INSOMNIA THERAPEUTICS INCORPORATED (OTCMKTS:BKIT) Have Gas After Even More Sellers Involved?

The stock of BLAKE INSOMNIA THERAPEUTICS INCORPORATED (OTCMKTS:BKIT) registered an increase of 122.22% in short interest. BKIT’s total short interest was 2,000 shares in November as published by FINRA. Its up 122.22% from 900 shares, reported previously. With 900 shares average volume, it will take short sellers 2 days to cover their BKIT’s short positions. The stock last traded at $1.08 per share. It is down 37.21% since April 22, 2016 and is downtrending. It has underperformed by 42.62% the S&P500.

Blake Insomnia Therapeutics, Inc., formerly Book It Local, Inc., is a pharmaceutical company, which is focused on improving nighttime and daytime quality of life for people with insomnia. The company has a market cap of $35.44 million. The Company’s Zleepax is a sleep aid with beta blockers as an active agent. It currently has negative earnings. Zleepax employs beta blockers to disrupt the circle of stress leading to insomnia.

BKIT Company Profile

Blake Insomnia Therapeutics, Inc., formerly Book It Local, Inc., incorporated on August 11, 2012, is a pharmaceutical company, which is focused on improving nighttime and daytime quality of life for people with insomnia. The Company’s Zleepax is a sleep aid with beta blockers as an active agent. It is focused on stress-related insomnia. Zleepax employs beta blockers to disrupt the circle of stress leading to insomnia. The Firm is raising capital to finance Phase II clinical testing of Zleepax. It is a development-stage company.

Another recent and important Blake Insomnia Therapeutics Inc (OTCMKTS:BKIT) news was published by Reuters.com which published an article titled: “Dead college football player leaves clues of concussions’ toll on brain” on January 04, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Richard Conner


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>